- California Bill Increases Pharmacist Powers – New bill allows pharmacists to initiate HIV medication. (drugtopics.com)SB-159 HIV: preexposure and postexposure prophylaxis. (leginfo.legislature.ca.gov)
California Governor Gavin Newsom signed into law last month new legislation that allows pharmacists in the state to initiate and dispense HIV medication without a prescription. The law, SB159, was amended to say that “a pharmacist may initiate and furnish HIV preexposure prophylaxis” and “a pharmacist may initiate and furnish HIV postexposure prophylaxis.” Previously, only pharmacists in specific collaborative practice agreements were able to dispense the drugs independently.In order to dispense either preexposure prophylaxis (PrEP) or postexposure prophylaxis (PEP), pharmacists will need to complete a boardapproved training program, according to the law...READ MORE
- This Week in Managed Care: December 6, 2019 (ajmc.com)
Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network
- Blink Health offers free medications on various prescriptions (drugstorenews.com)
Blink Health, a digital health company, is getting into the holiday spirit by offering new patients more than 4,000 medications for free...“Prescription drug prices are simply too high for too many people. We have all heard the tragic stories of people having to decide between taking their medications and eating, or cutting pills in half to save money — that’s simply not acceptable...” Geoff Chaiken, Blink Health CEO said. “...we’re focused on fixing that problem by putting the interests of patients first — not large corporations.”...New patients who sign up and order their first prescription through Blink Health will be provided with a credit of up to $10 off their first order, which covers many of the most popular prescription drugs available through Blink Health...READ MORE
- Ex-Outcome Health execs hit with criminal charges alleging $1B fraud scheme (fiercepharma.com)
The co-founders of Outcome Health and several former executives have been charged by the Department of Justice in a $1 billion fraud scheme targeting clients, lenders and investors...The DOJ...charging Rishi Shah and Shradha Agarwal, the co-founders...along with Brad Purdy, former chief operating officer and chief financial officer and Ashik Desai, former executive vice president of business operations...At the same time, the Securities and Exchange Commission...added the executives to its civil complaint, alleging they falsely portrayed the company’s success to investors and auditors to the tune of $487 million...The DOJ filing alleges that from 2011 to 2017, the executives bilked mostly pharma companies by selling them “tens of millions of dollars of advertising inventory that did not exist.” The indictment claims the faux sales resulted in inflated financial statements that were then used to raise financing in 2016 and 2017...READ MORE
- Automation, tech companies rethink pharmacy pain points (drugstorenews.com)The Future of Pharmacy Automation (drugtopics.com)The Pros and Cons of Pharmacy Automation (drugtopics.com)
Pharmacists have taken their rightful place in the delivery of health care, engaging with patients and making a noticeable improvement in their patients’ health outcomes. As the clinical role of pharmacists has grown, so too has the imperative to fill an ever-increasing number of prescriptions in a day. As a result, pharmacy technology and automation companies are stepping up to the plate to ensure that pharmacists can juggle their role successfully...READ MORE
- Speeding up Dispensing
- Rethinking Processes
- Software and Workflow
- December 6 Pharmacy Week in Review (pharmacytimes.com)
Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- FDA Warns 15 Companies Selling CBD Products (ptcommunity.com)
The FDA has issued warning letters to 15 companies for illegally selling products containing cannabidiol in ways that violate the Federal Food, Drug, and Cosmetic Act...“We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,’” said FDA Principal Deputy Commissioner Amy Abernethy,...“Aside from one prescription drug approved to treat two pediatric epilepsy disorders, these products have not been approved by the FDA and we want to be clear that a number of questions remain regarding CBD’s safety—including reports of products containing contaminants, such as pesticides and heavy metals— and there are real risks that need to be considered.”...READ MORE
- FDA Approving Drugs at Breakneck Speed, Raising Alarm (msn.com)
The U.S. is approving new drugs so fast that companies are now preparing for a green light months in advance of the scheduled decision date, a pace that’s helping patients with rare or untreatable diseases but raising alarm among consumer advocates...“It isn’t that we changed our policies and are saying we are going to approve drugs faster,” said Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research...“The difference now is we are going to see more of those because of the science. If there are people out there with no options and they have terrible diseases, we are going to get those drugs to them as fast as feasible.”...READ MORE
- Texas Safe Drug Disposal Law Goes Into Effect January (ptcommunity.com)
Texas Governor Greg Abbott signed into law HB 2088, which requires that all pharmacists who dispense Schedule II controlled substances provide written notice on the safe disposal of controlled substances unless the dispensing pharmacy is authorized to take back those drugs for disposal, regularly accepts those drugs for safe disposal or provides the patient—at no cost—"chemicals to render the unused drugs unusable" or a mail-in pouch. This law goes into effect on January 1, 2020...DisposeRx, which has a network of more than 2,000 pharmacies in Texas, is working to help pharmacists and pharmacies comply with HB 2088 via safe, at-home disposal packets and patient education...READ MORE
- Will sky-high drug prices spur the US to use an obscure power over patents? (biopharmadive.com)
With the major Democratic 2020 candidates campaigning on lowering drug prices, march-in rights are now back in focus as a tool to achieve that goal. Biopharmas are setting too-high prices for drugs discovered with taxpayer support, the argument goes, which ought to spur the government to take possession of their patents to lower costs. The Trump administration also has shown some interest in pharma patents...The calls are only growing thanks to "patent thickets," the expansive intellectual property estates that drugmakers use to shield drugs from generic competition well beyond the date of first patent expiration...The problem with appealing to march-in rights as a solution is the government has always refused to use the power it holds...READ MORE










